RJT
ITCI
Raymond James Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $234K | Sell |
3,199
-16
| -0.5% | -$1.17K | 0.01% | 1168 |
|
|
2024
Q2 | $220K | Sell |
3,215
-194
| -6% | -$13.3K | 0.01% | 1147 |
|
|
2024
Q1 | $236K | Buy |
3,409
+287
| +9% | +$19.9K | 0.01% | 1109 |
|
|
2023
Q4 | $224K | Buy |
+3,122
| New | +$224K | 0.01% | 1088 |
|
|
2023
Q3 | – | Sell |
-3,248
| Closed | -$206K | – | 1217 |
|
|
2023
Q2 | $206K | Buy |
+3,248
| New | +$206K | 0.01% | 1099 |
|
|
2022
Q4 | – | Sell |
-4,467
| Closed | -$208K | – | 1172 |
|
|
2022
Q3 | $208K | Buy |
4,467
+106
| +2% | +$4.94K | 0.01% | 975 |
|
|
2022
Q2 | $249K | Sell |
4,361
-215
| -5% | -$12.3K | 0.01% | 905 |
|
|
2022
Q1 | $280K | Sell |
4,576
-767
| -14% | -$46.9K | 0.01% | 920 |
|
|
2021
Q4 | $280K | Buy |
+5,343
| New | +$280K | 0.01% | 933 |
|
|
2021
Q3 | – | Sell |
-4,933
| Closed | -$201K | – | 1174 |
|
|
2021
Q2 | $201K | Buy |
+4,933
| New | +$201K | 0.01% | 1067 |
|